Biggest coronavirus vaccine deal yet: $2.1 billion to Sanofi/GSK for up to 100 million doses

The United States will pay Sanofi and GlaxoSmithKline up to $2.1 billion to test and produce 100 million doses of an experimental coronavirus vaccine.